• Twitter
  • RSS
InterveXion Therapeutics
  • About Us
    • Overview
    • Management Team
    • Financial Conflict of Interest
  • Research & Development
    • Anti-Methamphetamine Products
    • Intellectual Property
    • Methamphetamine Use Disorder
  • Publications
    • Recent Publications
    • Anti-Methamphetamine Monoclonal Antibody
    • METH Vaccine
    • Anti-Phencyclidine Monoclonal Antibody
    • Review Articles
  • Contact Us
  • News
Select Page

Overshadowed By Opioids, Meth Is Back And Hospitalizations Surge | Kaiser Health News

Nov 27, 2018 | METH in the news

The number of people hospitalized because of amphetamine use is skyrocketing in the United States, but the resurgence of the drug largely has been overshadowed by the nation’s intense focus on opioids.

Source: Overshadowed By Opioids, Meth Is Back And Hospitalizations Surge | Kaiser Health News

Submit a Comment Cancel reply

Your email address will not be published. Required fields are marked *

Recent Posts

  • Pharmacotherapy for Stimulant Use Disorders: A Systematic Review – NCBI Bookshelf
  • Meth on the rise in New Jersey
  • Meth And Cocaine Are Spurring a “Fourth Wave” Of The Overdose Crisis
  • Drugs Most Frequently Involved in Drug Overdose Deaths: United States, 2011–2016
  • A ‘Beautiful Boy’s’ Struggle: What You Need To Know About Methamphetamine Addiction

Recent Comments

    Archives

    • February 2019
    • January 2019
    • December 2018
    • November 2018
    • May 2018
    • January 2018
    • October 2017
    • June 2017
    • January 2016
    • January 2015
    • November 2014
    • February 2014
    • August 2013
    • July 2013
    • December 2012
    • November 2012
    • May 2012
    • April 2012
    • July 2011
    • April 2011
    • October 2009
    • September 2009
    • March 2005
    • January 2005

    Categories

    • Anti-METH ch-mAb7F9
    • Anti-METH Vaccine
    • Anti-PCP ch-mAb6B5
    • General News
    • Grants
    • METH in the news
    • Uncategorized

    Meta

    • Log in
    • Entries RSS
    • Comments RSS
    • WordPress.org
    • Twitter
    • RSS
    © 2017 Intervexion